James Singleton

James Singleton

Company: Numab Therapeutics

Job title: General Counsel

Seminars:

Presentation: Innovative Funding Models for Capital-Intensive Biopharma Ventures 11:30 am

How can biopharma companies secure funding beyond traditional equity markets? Understand venture capital, private equity, and non-dilutive financing strategies Manage regulatory and contractual challenges in alternative financing agreementsRead more

day: Day 1

Panel Discussion: What Legal Teams Need to Know About Raising Capital in an Uncertain Market 1:00 pm

How are investors evaluating biopharma opportunities in today’s economic climate? Legal risks and compliance challenges in securing funding amid financial uncertainty Practical strategies for legal teams to support successful fundraising effortsRead more

day: Day 1

Panel Discussion: Preparing for the M&A & Deal Surge to Maximize Biopharma Growth & Survival 3:15 pm

Insights on how large pharma companies are targeting acquisitions to fuel growth Structuring deals to protect biotech’s and enhance appeal during M&A prep How legal teams can balance the needs of both parties to ensure a successful deal and navigate post-merger integrationRead more

day: Day 1

Chair’s Opening Remarks 8:50 am

Read more

day: Day 1

Chair’s Closing Remarks 4:15 pm

Read more

day: Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.